These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39173500)

  • 1. miR-185-5p rewires cisplatin resistance by restoring miR-203a-3p expression via downregulation of SOX9.
    Biswal P; Mallick B
    DNA Repair (Amst); 2024 Oct; 142():103750. PubMed ID: 39173500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
    Wang J; Jia J; Zhou L
    Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma.
    Yan J; Xu H
    Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
    Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
    J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
    Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L
    Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
    Chen L; Zhu Q; Lu L; Liu Y
    Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
    Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
    Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
    Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA HOXD-AS1 promotes oral squamous cell carcinoma by sponging miR-203a-5p.
    Zhang Y; Wang F; Yu Y
    Oral Dis; 2023 May; 29(4):1505-1512. PubMed ID: 35152529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma
    Kang SH; Oh SY; Lee KY; Lee HJ; Kim MS; Kwon TG; Kim JW; Lee ST; Choi SY; Hong SH
    Theranostics; 2024; 14(2):460-479. PubMed ID: 38169528
    [No Abstract]   [Full Text] [Related]  

  • 14. Circ_0109291 Promotes Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188-3p to Increase
    Gao F; Han J; Wang Y; Jia L; Luo W; Zeng Y
    Cancer Biother Radiopharm; 2022 May; 37(4):233-245. PubMed ID: 32758011
    [No Abstract]   [Full Text] [Related]  

  • 15. MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.
    Liu Y; Zhang Y; Li Q; Xu R; Huang N
    Thorac Cancer; 2022 Jul; 13(13):1974-1985. PubMed ID: 35599447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression.
    Wang L; Zhang Z; Yu X; Li Q; Wang Q; Chang A; Huang X; Han X; Song Y; Hu J; Pang L; Hou J; Li F
    Cancer Lett; 2020 Jan; 468():14-26. PubMed ID: 31600529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
    Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutic Drug Resistance Associated with Differential miRNA Expression of miR-375 and miR-27 among Oral Cancer Cell Lines.
    Huni KC; Cheung J; Sullivan M; Robison WT; Howard KM; Kingsley K
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SP2-induced circPUM1 modulates chemoresistance and nature killer cell toxicity in oral squamous cell carcinoma.
    Liu L; Zou C; Lv X; Wei H; Wu S; Song J; Tang Z; Luo H; Li X; Ai Y
    J Cell Mol Med; 2024 Mar; 28(5):e17888. PubMed ID: 37556099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.